International Vaccine Institute (IVI) | IAS Target IAS Target

International Vaccine Institute (IVI)

The International Vaccine Institute (IVI) is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory for vaccine development and evaluation in the field to facilitate the sustainable introduction. IVI was established as an initiative of the UN Development Programme (UNDP). IVI began formal operations as an independent international organization in 1997 in Seoul, Republic of Korea.

IVI Independent, nonprofit, international organization
Headquarters Seoul, Republic of Korea
Membership 35 member states and the World Health Organization
Formation October 9, 1997
Founder United Nations Development Programme

Objective

  • Discover, develop, and deliver safe, affordable and effective vaccines for global public health.
  • Health of children in developing countries can be dramatically improved by the use of new and improved vaccines
  • Unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions

IVI Working in collaboration with:

  • The international scientific community
  • Public health organizations
  • Governments and Industry

India and IVI

  • The move involves payment of the annual contribution of US $ 5,00,000 to the International Vaccine Institute (IVI).
  • The Union Cabinet has given its approval to the proposal for India’s taking full membership of the International Vaccine Institute (IVI) Governing Council.